Legal Archives - Life Sciences Times

Novartis to Invest $23 Billion in Expanding U.S. Manufacturing and Research Footprint

April 13, 2025

Congressional Commission Calls for $15 Billion Boost to U.S. Biotechnology Sector

April 12, 2025

FDA Unveils Historic Shift Away from Animal Testing for Drug Development

April 12, 2025

THIS WEEK'S STORIES

RenovoRx Boosts U.S. Production of RenovoCath Devices Amid Rising Demand from Oncology Sector

April 16, 2025

Sollis Health Names Katy Marshall Chief Growth Officer

April 14, 2025

Vaxess Secures $9 Million to Advance Needle-Free Drug Delivery Platform

April 10, 2025

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Legal

Veteran Life Sciences Attorney Danielle Naftulin Joins Wilson Sonsini as Partner

Vizgen Reaches Settlement with 10x Genomics and Harvard University, Ending Multi-Jurisdictional Patent Dispute

Greenberg Traurig’s Life Sciences & Medical Technology Group Named Finalist for Three LSPN Awards

U.S. Patent Trial and Appeal Board Institutes Inter Partes Review Based on Geneoscopy’s Petition Challenging Validity of ‘781 Patent Owned by Exact Sciences

biomodal Files Patent Infringement Lawsuit Against New England Biolabs

Most Read

Third Harmonic Bio Announces Plan to Liquidate and Dissolve Company

Profluent Unveils ProGen3, Marking a Milestone in AI-Powered Protein Design

Mural Oncology to Halt Drug Development, Explore Strategic Alternatives, to Lay Off 90% of its workforce

Sware Tapped to Validate AI-Driven GxP Compliance for Salesforce Life Sciences Cloud

EDITOR PICKS